# Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention

> **NCT04040946** · PHASE3 · COMPLETED · sponsor: **Centre Francois Baclesse** · enrollment: 59 (actual)

## Conditions studied

- Parathyroid Adenoma
- Hyperparathyroidism
- F18-choline

## Interventions

- **DIAGNOSTIC_TEST:** MIBI scintigraphy
- **DIAGNOSTIC_TEST:** F18-choline PET

## Key facts

- **NCT ID:** NCT04040946
- **Lead sponsor:** Centre Francois Baclesse
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-19
- **Primary completion:** 2022-05-05
- **Final completion:** 2023-06-30
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04040946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04040946, "Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04040946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*